The expression of TRPV2 was clearly positively correlated with immune and stromal scores in most cancers (Figure 4), except KIRP, PCPG, THYM, and UCS, in which the correlation between stromal score and TRPV2 was not significant. This evidence concerns the gene TRPV2 and cancer.